China's memory chip industry just crossed a symbolic threshold. ChangXin Memory Technologies (CXMT), the country's largest DRAM maker, has begun producing HBM3E chips — high-bandwidth memory used in AI processors — in small quantities. It sounds like a breakthrough. It is. But calling it a "breakthrough" without context is like calling a toddler's first steps a marathon finish.
For the first time, China has domestic HBM3E capability. That matters because HBM is the bottleneck component in every major AI accelerator — from Nvidia's H100 to AMD's Instinct series. Until now, that market has been an oligopoly of three players: SK Hynix, Samsung, and Micron. CXMT's entry, even at a fraction of their capability, changes the geometry of the game.
What CXMT Has Actually Built
According to reports citing two insiders, CXMT is producing HBM3E in small quantities. They've already been shipping HBM3 samples to Huawei since the second half of 2025. The chips use a 16nm process with 8-high stacks — eight individual DRAM dies layered vertically and connected with through-silicon vias.
Mass production of HBM3 is targeted for the end of 2026. HBM3E, which offers higher bandwidth and improved power efficiency, is anticipated for 2027. That timeline tracks with estimates from SemiAnalysis, which put CXMT's yield rates at around 25% for 8-high stacks as of June 2026.
Let that sink in: three out of every four chip stacks don't make it through quality testing. For context, mature HBM production lines at SK Hynix and Samsung run significantly higher. The gap isn't just technical — it's economic. Every defective stack is money burned.
The Equipment Problem Nobody Can Ignore
CXMT's biggest structural challenge isn't ambition or capital. It's that they can't buy the right tools. US-led export controls have blocked Chinese chipmakers from acquiring extreme ultraviolet (EUV) lithography machines — the cutting-edge equipment made exclusively by Dutch firm ASML.
Without EUV, CXMT relies on deep ultraviolet (DUV) lithography. DUV can still produce functional chips, but it requires more processing steps, results in larger feature sizes, and generally caps how competitive the end product can be against chips made with EUV. For HBM specifically, this constraint affects both the density and power efficiency of the memory stacks CXMT can produce.
Meanwhile, SK Hynix is already shipping HBM4 in volume. Samsung and Micron are in similar positions. The technology gap is roughly three to five generations — or as The Information puts it, CXMT is "three to five years behind technically."
The IPO That Broke Records
CXMT's July 2026 debut on the Shanghai STAR Market was spectacular. The company raised approximately 57.9 billion yuan (roughly $8.6 billion), and on its first day of trading, the stock surged about 466%, pushing the company's valuation to approximately 3.3 trillion yuan ($489 billion).
For the first half of 2026, CXMT reported revenue of 150.3 billion yuan — an 874% year-over-year increase. Net profit hit 77.6 billion yuan. Those gains are largely driven by strong DRAM pricing and AI-related supply constraints rather than HBM revenue specifically. Traditional DRAM, the kind that goes into servers, PCs, and phones, still accounts for the bulk of CXMT's output.
However, not a single dollar of that $8.6 billion IPO raise is earmarked for HBM development, according to the prospectus. The money is going toward expanding traditional DRAM capacity, which is expected to reach 300,000 to 350,000 wafers per month by end of 2026.
Why This Matters for China's AI Ambitions
The real significance of CXMT's HBM3E push isn't about beating SK Hynix tomorrow. It's about China's AI self-sufficiency under export restrictions. With US rules limiting the purchase of advanced HBM chips, Chinese AI chipmakers like Huawei need a domestic source — even at 25% yields and older process nodes.
Alibaba's T-Head and Cambricon are already testing CXMT's HBM3 and plan to use it in products starting in 2027. That creates a captive ecosystem: Chinese AI chips made with Chinese memory, insulated from export control uncertainty.
If CXMT achieves HBM3 mass production by late 2026 or early 2027 — even at modest volumes — it could ease pricing pressure in China's domestic market while having limited direct impact on global HBM pricing. The more interesting scenario comes later: if CXMT can close the technology gap and push into HBM3E at meaningful scale by 2027, it becomes a genuine fourth competitor in a market that has operated as a three-player oligopoly.
🔥 Hot Takes
1. 25% yields are a feature, not a bug — for Beijing. The Chinese government isn't betting on CXMT winning on cost or performance. They're betting on CXMT winning on sovereignty. Every HBM3E stack that clears quality control is one less chip that could be denied by US export controls. Yield rates will improve; the strategic necessity is immediate.
2. The $8.6B IPO was never about HBM — it was about funding the war machine. CXMT's prospectus didn't allocate IPO proceeds to HBM because Beijing doesn't need CXMT to be profitable. It needs them to exist. The 874% revenue surge proves the business works; the HBM push proves the strategy is working too, just on a different timeline.
3. SK Hynix should sleep tonight — but not too soundly. Yes, CXMT is 3-5 years behind. Yes, yields are abysmal. But China has been building AI chip self-sufficiency for a decade, and every "impossible" milestone has been crossed faster than Western analysts predicted. The memory oligopoly isn't ending today. But the cracks are forming.
Bottom line: CXMT's HBM3E is a real achievement — just not the world-changing one headlines imply. It's a strategic milestone for China's AI independence, a proof of concept for domestic HBM production, and a signal to Huawei and other Chinese AI chipmakers that they have an alternative. But until yields climb and EUV access is secured (or circumvented), CXMT remains a regional player in a global market. The gap is narrowing, but it's still wide enough to matter.